Abstract
AIMS AND METHOD: Response to antidepressants depends on patients' use. Our objective is to take a look over antidepressants use in a real sample. In determining relevant factors, data were gathered from 550 patients, currently taking antidepressants. The questionnaire included two items, patients' perceived difficulty of following treatment and level of acknowledged non-compliance, which may be considered as a way of approximating the patients' real use of treatment. RESULTS: compliance was poor among the less educated, living in rural areas and receiving concomitant treatment. Use perceived as good in 61.5%, better in affective disorder (69.8%). Patients without response present higher incidence of non-compliance (49.1%). It should be mandatory to explore and reinforce a good use of antidepressants in clinical settings, particularly if the indication is not an affective disorder and in case of multiple treatments, rural setting, and lower educational level. If response is inadequate, compliance must be revised specially.
Keywords: Adherence, antidepressant, antidepressant indication, compliance, patients' perception, treatment response, use of treatment, Venlafaxine, hypochondriac depressive symptoms
Current Drug Therapy
Title: Use and Results of Antidepressant Treatment: Patients' Perception
Volume: 6 Issue: 4
Author(s): Maria-Jose Martin-Vazquez, Mauro Garcia-Toro, Francisco Campoamor, Antonio Pareja, Iratxe Aguirre, Joan Salva and Miquel Roca
Affiliation:
Keywords: Adherence, antidepressant, antidepressant indication, compliance, patients' perception, treatment response, use of treatment, Venlafaxine, hypochondriac depressive symptoms
Abstract: AIMS AND METHOD: Response to antidepressants depends on patients' use. Our objective is to take a look over antidepressants use in a real sample. In determining relevant factors, data were gathered from 550 patients, currently taking antidepressants. The questionnaire included two items, patients' perceived difficulty of following treatment and level of acknowledged non-compliance, which may be considered as a way of approximating the patients' real use of treatment. RESULTS: compliance was poor among the less educated, living in rural areas and receiving concomitant treatment. Use perceived as good in 61.5%, better in affective disorder (69.8%). Patients without response present higher incidence of non-compliance (49.1%). It should be mandatory to explore and reinforce a good use of antidepressants in clinical settings, particularly if the indication is not an affective disorder and in case of multiple treatments, rural setting, and lower educational level. If response is inadequate, compliance must be revised specially.
Export Options
About this article
Cite this article as:
Martin-Vazquez Maria-Jose, Garcia-Toro Mauro, Campoamor Francisco, Pareja Antonio, Aguirre Iratxe, Salva Joan and Roca Miquel, Use and Results of Antidepressant Treatment: Patients' Perception, Current Drug Therapy 2011; 6 (4) . https://dx.doi.org/10.2174/157488511798109619
DOI https://dx.doi.org/10.2174/157488511798109619 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Inhibitors of 11β-HSD1: A Potential Treatment for the Metabolic Syndrome
Current Topics in Medicinal Chemistry Correlations Between Carotid IMT, Factor VIII Activity Level and Metabolic Disturbances: A Cardio-Vascular Risk Factor in the HIV Positive Persons
Current HIV Research Hypertriglyceridaemia, Postprandial Lipaemia and Non-HDL Cholesterol
Current Pharmaceutical Design Molecular Mechanisms of Neuronal Histamine and its Receptors in Obesity
Current Molecular Pharmacology Uncommon Association Between Diabetic Ketoacidosis, Thyrotoxicosis, Cutaneous Abscess and Acute Pericarditis in an Immunocompetent Patient: A Single Case Report and Literature Review
Current Diabetes Reviews Long-Term Metabolic Consequences in Patients with a History of Gestational Diabetes
Current Pharmaceutical Design (Pro)renin Receptor: Pathological Role and Therapeutic Potential in Primary Hypertension
Current Hypertension Reviews The Application of Micro-Analytical Techniques to Biomedical Analysis
Current Pharmaceutical Analysis Controlled and Continuous Release Ocular Drug Delivery Systems: Pros and Cons
Current Drug Delivery Gestational Diabetes and the Metabolic Syndrome: Can Obesity and Small, Dense Low Density Lipoproteins be Key Mediators of this Association?
Current Pharmaceutical Biotechnology Elevated Heart Rate, A Risk Factor and Risk Marker of Cardiovascular Disease
Current Hypertension Reviews Pharmacological Intervention in Type 2 Diabetes Mellitus – A Pathophysiologically Reasoned Approach?
Current Diabetes Reviews Clinical Applications of Transcranial Doppler Sonography
Reviews on Recent Clinical Trials Cardiovascular Complications of Sleep Disorders: A Better Night’s Sleep for a Healthier Heart / From Bench to Bedside
Current Vascular Pharmacology Benign Prostatic Hyperplasia and Clinical Prostate Cancer - Two New Components of the Metabolic Syndrome
Current Hypertension Reviews The Role of Unbound Drug in Pharmacokinetics/Pharmacodynamics and in Therapy
Current Pharmaceutical Design MicroRNAs in Cardiovascular Therapeutics
Current Topics in Medicinal Chemistry Aldose Reductase in Diabetic Microvascular Complications
Current Drug Targets A Critical Review on the Unexplored Therapeutic Treasure of Himalayan Ayurvedic Drug Daruharidra (<i>Berberis Aristata</i>)
Current Traditional Medicine Smoking and Congenital Heart Disease: The Epidemiological and Biological Link
Current Pharmaceutical Design